We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: rkrw who wrote (55)2/5/2006 3:06:25 AM
From: zeta1961   of 56
Rkrw..that answers my question re: are the situations very different!-g-...seriously..thanks

OK..I think I'm in denial that a Bahstohn biotech would be so silly as to spend all this investor dough on attorny fees when they knew it was a losing battle..esp. since the former CEO did indeed have patents!..I'm curious that the GLGS CEO left but the CFO has stayed..

I suppose that there are plenty of solid biotechs out there that are more worth my time for DD than this little pup!..I will keep an eye though to learn in real time how this gets handled..

Go Seattle SeaHawks!

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext